NFKB1 and breast cancer: This compound inhibits cell growth and induces apoptosis of luminal BC cells through the regulation of caspases, cytochrome c release, the NF-κB, PI3K, and Akt/mTOR pathways [263,264], and poly-ADP ribose polymerase (PARP) cleavage [217,218].